Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Strengthening systems in low resource settings

Prof Richard Sullivan - Kings College London, London, UK
Strengthening systems in low resource settings ( Prof Richard Sullivan - Kings College London, London, UK )
10 Oct 2017

Goals of the International Cancer Microbiome Consortium

Mr James Kinross - Imperial College London, London, UK
Goals of the International Cancer Microbiome Consortium ( Mr James Kinross - Imperial College London, London, UK )
22 Sep 2017

The microbiome revolution

Mr James Kinross - Imperial College London, London, UK
The microbiome revolution ( Mr James Kinross - Imperial College London, London, UK )
21 Sep 2017

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

Prof Jonathan Ledermann - University College London Hospitals, London, UK
ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients ( Prof Jonathan Ledermann - University College London Hospitals, London, UK )
11 Sep 2017

Initial results of inhibitor combination against breast and gynaecologic cancers

Dr Shannon Westin - MD Anderson Cancer Center, Houston, Texas
Initial results of inhibitor combination against breast and gynaecologic cancers ( Dr Shannon Westin - MD Anderson Cancer Center, Houston, Texas )
11 Sep 2017

Chemoradiation remains best treatment for locally advanced cervical cancer

Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India
Chemoradiation remains best treatment for locally advanced cervical cancer ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )
11 Sep 2017

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
LORELEI trial of letrozole and taselisib for ER positive breast cancer ( Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017

Nivolumab and ipilimumab for metastatic kidney cancer

Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
Nivolumab and ipilimumab for metastatic kidney cancer ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
11 Sep 2017

BRIM8: Vemurafenib in high risk melanoma patients

Dr Karl Lewis - University of Colorado Denver, Colorado, USA
BRIM8: Vemurafenib in high risk melanoma patients ( Dr Karl Lewis - University of Colorado Denver, Colorado, USA )
11 Sep 2017

COMBI-AD: Dabrafenib plus trametinib in advanced melanoma

Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
COMBI-AD: Dabrafenib plus trametinib in advanced melanoma ( Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )
11 Sep 2017